3.42
Precedente Chiudi:
$3.30
Aprire:
$3.28
Volume 24 ore:
262.20K
Relative Volume:
0.33
Capitalizzazione di mercato:
$261.92M
Reddito:
$4.72B
Utile/perdita netta:
$-123.85M
Rapporto P/E:
-0.2392
EPS:
-14.2981
Flusso di cassa netto:
$-303.12M
1 W Prestazione:
-4.74%
1M Prestazione:
+24.82%
6M Prestazione:
-82.02%
1 anno Prestazione:
-82.02%
Accendra Health Inc Stock (ACH) Company Profile
Nome
Accendra Health Inc
Settore
Industria
Telefono
(804) 277-4304
Indirizzo
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ACH
Accendra Health Inc
|
3.42 | 261.92M | 4.72B | -123.85M | -303.12M | -14.30 |
|
MCK
Mckesson Corp
|
805.96 | 94.36B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
303.44 | 59.04B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
235.80 | 55.23B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
84.40 | 9.61B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.52 | 1.30B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Downgrade | UBS | Buy → Neutral |
| 2024-07-19 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-12 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-10-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Ripresa | Citigroup | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-30 | Ripresa | JP Morgan | Underweight |
| 2022-03-23 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2021-04-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-03-08 | Aggiornamento | Goldman | Sell → Buy |
| 2020-12-17 | Aggiornamento | UBS | Neutral → Buy |
| 2020-09-25 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-01-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | Downgrade | Goldman | Neutral → Sell |
| 2019-11-15 | Aggiornamento | CLSA | Underperform → Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-10 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-03 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2019-01-18 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-15 | Aggiornamento | CLSA | Underperform → Outperform |
| 2018-12-14 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | Downgrade | Goldman | Buy → Neutral |
| 2018-09-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | Downgrade | CLSA | Outperform → Sell |
| 2018-04-10 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | Aggiornamento | Goldman | Sell → Neutral |
| 2017-11-02 | Downgrade | HSBC Securities | Buy → Hold |
| 2016-03-24 | Aggiornamento | Goldman | Sell → Neutral |
| 2015-12-07 | Downgrade | Goldman | Neutral → Sell |
| 2015-08-31 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | Iniziato | HSBC Securities | Underweight |
| 2009-08-05 | Aggiornamento | Citigroup | Sell → Buy |
| 2008-12-01 | Downgrade | HSBC Securities | Neutral → Underweight |
Mostra tutto
Accendra Health Inc Borsa (ACH) Ultime notizie
Enterprise value to revenue forward of Accendra Health Inc – SWB:6OM - TradingView
Price to sales forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health Concludes Exchange Offers for Senior Notes Due 2029 and 2030 - sekbernews.id
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds - Yahoo Finance
Price to sales forward of Accendra Health Inc – SWB:6OM - TradingView
Accendra Health (ACH) Sheds 1.5% as Shares Approach Key Support ZoneLow Volume Node - dars.gov.et
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
Accendra Health, Inc.(NYSE: ACH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Index - marketscreener.com
Accendra Health Inc Actuals & Estimates (NYSE:ACH) - TradingView
ACHAccendra Health Inc Options - Finviz
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Value Benchmark - marketscreener.com
Accendra Health Completes Major Exchange Offer, Restructures Debt - TipRanks
Accendra Health reports near-complete tenders in exchange offers, issues new secured notes - TradingView
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Accendra Health Reports Expiration of Exchange Offers, Final Tender Results - Moomoo
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations - Business Wire
ACH Q1 2026 Earnings: EPS Beat Drives Positive Market Response Despite Revenue UncertaintyEPS Estimate Trend - dars.gov.et
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accendra Health Inc. (ACH) Q1 2026 Earnings: Strong EPS Beat Signals Operational ImprovementFiscal Year Earnings - dars.gov.et
Accendra Health Announces Early Results of Exchange Offers and Consent Solicitations for Senior Notes - Minichart
Accendra Health Completes Major Debt Exchange and Refinancing - TipRanks
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue DisclosureEarnings Per Share - newsline.com
Accendra Health receives 99% participation in debt exchange offer - Investing.com UK
Accendra Health receives 99% participation in debt exchange offer By Investing.com - Investing.com Australia
Accendra Health Announces Early Results of Offers and Consent Solicitations - Business Wire
Accendra Health (ACH) Gains 4.71% as Momentum Builds Toward Key Resistance ZoneStock Surge Alerts - dars.gov.et
Are Options Traders Betting on a Big Move in Accendra Health Stock? - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats by 60.9% but Stock Declines on Revenue UncertaintyFinancial Data - newsline.com
Accendra Health (ACH) Q4 2025 earnings summary - Quartr
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats Estimates by 60.9% as Loss Narrows to $0.04 Per ShareConsensus Forecast Report - newsline.com
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 - Investing.com Nigeria
Owens & Minor Appoints Jim Marshall as Chief Executive Officer, Effective May 27, 2026 - marketscreener.com
Owens & Minor names former McKesson SVP as new CEO - MassDevice
Accendra Health Q1 2026 Earnings: EPS Beat Drives Positive Market ReactionShare Repurchase Impact - The Legal Advocate
Accendra Health launches debt exchange offer, seeks new financing By Investing.com - Investing.com Australia
Accendra Health launches debt exchange offer, seeks new financing - Investing.com UK
Accendra Health Launches Major Debt Exchange and Refinancing Plan - TipRanks
Accendra Health Launches Offering to Exchange Senior Notes - marketscreener.com
Accendra Health launches exchange offers to replace 2029/2030 notes with new secured notes, $326.25M new-money first-lien issue - TradingView
Accendra Health Announces Offers and Consent Solicitations - Yahoo Finance
Accendra Health (ACH) Edges Higher: Key Levels to Watch After +2.77% GainDiagonal Spread Trade - Newser
Accendra Health Inc Azioni (ACH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):